Review Article
Volume 9 Issue 6 - 2020
New York Corona Virus Epidemic in Bronx, NYC: Offense and Defense
Prashanth Thalanayar Muthukrishnan*
Attending Consultant and Assistant Professor of Medicine, Department of Pulmonary and Critical Care Medicine, North Central Bronx Hospital and Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA
*Corresponding Author: Prashanth Thalanayar Muthukrishnan, Attending Consultant and Assistant Professor of Medicine, Department of Pulmonary and Critical Care Medicine, North Central Bronx Hospital and Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Received: April 20, 2020; Published: May 21, 2020


From March 16th 2020 onwards, our university-affiliated hospital ICU (20 beds) started getting covid-19 patients in Acute Respiratory Distress Syndrome (ARDS), Acute Kidney Failure and Shock. By March 25th, all 20 (+2 flex) beds have had ventilator patients, about 2 - 3 being manually proned every day per unit (positioning patients on their belly to help open the lungs); we are learning to strategize the division of scarce labor and overcoming the fear of getting infected. Our civilian patients, nurses, physicians, administrators, housekeepers and assistants are providing exceptional support. We are providing help for nursing and physicians with multiple unstable patient events happening simultaneously. When the healthcare soldiers are stressed, hungry and thirsty, then the experience of serving these patients becomes painful and compromised. Although we are not trained to fight a world war, we know a good balance to the “offense” and “defense” section of the army helps us win the war. Nurses, doctors and assistant staff are the “soldiers” and the virus particles are the “opponents”. The “civilians” that fight alongside the soldiers during war are analogous to our patients. We need to balance being self-protective and self-destructive while serving for these patients if we want to fight till the end and save lives. Logistical experiences, teachings from various scriptures and world war strategies are described further in this article as seen at our hospital. We are learning unique strategies from other countries like India, how to address coronavirus public health thruchannels like Women’s health, Maternal and child health welfare.

Keywords: Acute Respiratory Distress Syndrome (ARDS); Corona Virus


  1. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet 10223 (2020): 497-506.
  2. Zheng M and Song L. “Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV”. Cellular and Molecular Immunology (2020).
  3. Kraft CS., et al. “The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States”. Clinical Infectious Diseases 4 (2015): 496-502.
  4. Van Griensven J., et al. “Evaluation of convalescent plasma for Ebola virus disease in Guinea”. The New England Journal of Medicine 1 (2016): 33-42.
  5. Florescu DF., et al. “Administration of brincidofovir and convalescent plasma in a patient with Ebola virus disease”. Clinical Infectious Diseases 6 (2015): 969-973.
  6. Zhou B., et al. “Treatment with convalescent plasma for influenza A (H5N1) infection”. The New England Journal of Medicine 14 (2007): 1450-1451.
  7. Casadevall A and Pirofski L-a. “The convalescent sera option for containing COVID-19”. Journal of Clinical Investigation (2020).
  8. Beigel JH., et al. “Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study”. The Lancet Infectious Diseases 4 (2018): 410-418.
  9. Robbins JB., et al. “Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum”. The Journal of Infectious Diseases 6 (1995): 1387-1398.
  10. Casadevall A and Pirofski LA. “Antibody-mediated regulation of cellular immunity and the inflammatory response”. Trends in Immunology 9 (2003): 474-478.
  11. Casadevall A and Scharff MD. “Serum therapy revisted: animal models of infection and development of passive antibody therapy”. Antimicrobial Agents and Chemother8 (1994): 1695-1702.
  12. Shen C., et al. “Treatment of 5 critically ill patients with COVID-19 with convalescent plasma”. The Journal of the American Medical Association (2020).
  13. Ye M Fu D., et al. “Treatment with convalescent plasma for COVID-19 patients in Wuhan, China”. Journal of Medical Virology (2020).
  14. Duan K., et al. “Effectiveness of convalescent plasma therapy in severe COVID-19 patients”. Proceedings of the National Academy of Sciences of the United States of America (2020).
  15. Zhang B., et al. “Treatment with convalescent plasma for critically ill patients with SARSCoV-2 infection”. Chest (2020): 30571-30577.
  16. Mair-Jenkins J., et al. “The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis”. The Journal of Infectious Diseases 1 (2015): 80-90.
  17. Cheng Y., et al. “Use of convalescent plasma therapy in SARS patients in Hong Kong”. European Journal of Clinical Microbiology and Infectious Diseases 1 (2005): 44-46.
  18. Yeh KM., et al. “Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital”. Journal of Antimicrobial Chemotherapy 5 (2005): 919-922.
  19. Zhang JS., et al. “A serological survey on neutralizing antibody titer of SARS convalescent sera”. Journal of Medical Virology 2 (2005): 147-150.
  20. Van Erp EA., et al. “Fc-mediated antibody effector functions during respiratory syncytial virus infection and disease”. Frontiers in Immunology 10 (2019): 548.
  21. Ko JH., et al. “Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience”. Antiviral Therapy 7 (2018):617-622.
  22. Hung IF., et al. “Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection”. Clinical Infectious Diseases 4 (2011): 447-456.
  23. Luke TC., et al. “Hark back: passive immunotherapy for influenza and other serious infections”. Critical Care Medicine 4 (2010): e66-e73.
  24. Gajic O., et al. “Transfusion-related acute lung injury in the critically ill: prospective nested case-control study”. American Journal of Respiratory and Critical Care Medicine 9 (2007): 886-891.
  25. Wan Y., et al. “Molecular mechanism for antibody-dependent enhancement of coronavirus entry”. Journal of Virology 5 (2020): e02015-e02019.
  26. China puts 245 COVID-19 patients on convalescent plasma therapy. News release”. Xinhua (2020).
  27. Crowe JE., et al. “Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines”. Journal of Immunology 7 (2001): 3910-3918.
Citation: Prashanth Thalanayar Muthukrishnan. “New York Corona Virus Epidemic in Bronx, NYC: Offense and Defense”. EC Pulmonology and Respiratory Medicine 9.6 (2020): 57-64.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for July Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the June issue of respective journals. Submissions are accepted on/before June 11, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to